Tag: NVCR Stock Price

Stock Investing

What Is The Reason Behind Novocure (NVCR) Stock Increasing 67% Pre-Hours Session?

Following positive results from its research to treat malignancies, NovoCure Limited (NASDAQ: NVCR) shares jumped 67.57% to $118.19 on Thursday morning. Which NVCR study had fruitful outcomes? The LUNAR study showed a statistically significant and clinically significant increase in overall survival above conventional therapy alone,

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.